机译:通过体外刺激肿瘤抗原脉冲自体树突状细胞恢复晚期乳腺癌患者肿瘤浸润淋巴细胞中的肿瘤特异性HLA I类限制性细胞毒性
Department of General Surgery University of Arkansas for Medical Sciences;
Division of Gynecologic Oncology University of Arkansas for Medical Sciences;
Division of Gynecologic Oncology University of Arkansas for Medical Sciences;
Division of Gynecologic Oncology University of Arkansas for Medical Sciences;
Division of Gynecologic Oncology University of Arkansas for Medical Sciences;
Department of General Surgery University of Arkansas for Medical Sciences;
Department of Medicine University of Arkansas for Medical Sciences;
Department of Microbiology and Immunology University of Arkansas for Medical Sciences;
Department of General Surgery University of Arkansas for Medical Sciences;
Division of Gynecologic Oncology University of Arkansas for Medical SciencesDivision of Gynecologic Oncology University of Brescia;
breast cancer; CTLs; dendritic cells; TIL; tumor lysate;
机译:通过用肿瘤抗原脉冲自体树突状细胞体外刺激,恢复特定于肿瘤的HLA I类限制了晚期乳腺癌患者的肿瘤浸润淋巴细胞的细胞毒性。
机译:肿瘤抗原脉冲自体树突状细胞体外诱导患有局部晚期乳腺癌的患者的肿瘤特异性HLA I类限制性CD8 +细胞毒性T淋巴细胞。
机译:通过树突状细胞刺激晚期卵巢癌患者的肿瘤浸润淋巴细胞恢复特定于肿瘤的人类白细胞抗原I类限制的细胞毒性。
机译:肿瘤细胞中的敲击表达水平定义了MHC类I肽的性质和加工,用于通过肿瘤特异性细胞毒性T淋巴细胞识别
机译:使死者复活:树突状细胞交叉呈递来自凋亡细胞的抗原,并诱导病毒和肿瘤特异性的细胞毒性T淋巴细胞。
机译:自体肿瘤RNA转染的树突状细胞在癌症患者中诱导肿瘤特异性细胞毒性T淋巴细胞的诱导
机译:肿瘤细胞刺激后肾细胞癌患者肿瘤特异性细胞毒性T淋巴细胞的诱导和克隆膨胀